James B. Tananbaum

Foresite Capital Management Vi Llc

Assets Managed

$460.271M

Holdings

Last Quarter

2026 - Q1

Filed Date

11d ago

Growth Rate

39.13%(2Q avg: 33.47%)

Sustained Growth

3 quarters

Portfolio positions

This chart displays the top 10 holdings in Foresite Capital Management Vi Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 17 positions.

Assets under management

The assets under management (AUM) of Foresite Capital Management Vi Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 460.271M in assets, with a quarterly growth rate of 39.13% and a 2-quarter average growth rate of 33.47%. The portfolio is managed by James B. Tananbaum, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
CGON Cg Oncology Inc Recent Activity	32.67%	$150.349M 2.221M shares@ $67.68 avg price
ALMS Alumis Inc Recent Activity	20.34%	$93.576M 4.248M shares@ $22.03 avg price
CNTA Centessa Pharmaceuticals-adr Recent Activity	11.78%	$54.179M 1.364M shares@ $39.73 avg price
CRVS Corvus Pharmaceuticals Inc Recent Activity Increased 32.58%	5.83%	$26.791M 1.831M shares@ $14.64 avg price	Increased 32.58%
DNLI Denali Therapeutics Inc Recent Activity Increased 21%	5.05%	$23.231M 1.21M shares@ $19.2 avg price	Increased 21%
AGIO Agios Pharmaceuticals Inc Recent Activity Decreased -0.94%	3.86%	$17.761M 525,000 shares@ $33.83 avg price	Decreased -0.94%
VSTM Verastem Inc Recent Activity Increased 0.37%	3.63%	$16.677M 3.147M shares@ $5.3 avg price	Increased 0.37%
KYMR Kymera Therapeutics Inc Recent Activity	2.65%	$12.188M 146,332 shares@ $83.29 avg price
NERV Minerva Neurosciences Inc Recent Activity New Position	2.61%	$11.969M 1.987M shares@ $6.03 avg price	New Position
CLDX Celldex Therapeutics Inc Recent Activity New Position	2.18%	$10.021M 315,913 shares@ $31.72 avg price	New Position

1-10 of 17